BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10563174)

  • 1. [Timely screening routines for prostatic cancer by Norwegian physicians].
    Fosså SD; Eri LM
    Tidsskr Nor Laegeforen; 1999 Oct; 119(24):3572-6. PubMed ID: 10563174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.
    Bunting PS; Goel V; Williams JI; Iscoe NA
    CMAJ; 1999 Jan; 160(1):70-5. PubMed ID: 9934349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing use of the prostate-specific antigen screening test in primary care.
    Moran WP; Cohen SJ; Preisser JS; Wofford JL; Shelton BJ; McClatchey MW
    Am J Manag Care; 2000 Mar; 6(3):315-24. PubMed ID: 10977432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attitudes and practices of primary care physicians for prostate cancer screening.
    Hoffman RM; Papenfuss MR; Buller DB; Moon TE
    Am J Prev Med; 1996; 12(4):277-81. PubMed ID: 8874692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practice patterns in screening and management of prostate cancer in elderly men.
    Konety BR; Sharp VJ; Verma M; Williams RD;
    Urology; 2006 Nov; 68(5):1051-6. PubMed ID: 17095076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for prostate cancer: a comparison of urologists and primary care physicians.
    McKnight JT; Tietze PH; Adcock BB; Maxwell AJ; Smith WO; Nagy MC
    South Med J; 1996 Sep; 89(9):885-8. PubMed ID: 8790311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer and prostate-specific antigen (PSA) screening in Austria.
    Vutuc C; Schernhammer ES; Haidinger G; Waldhör T
    Wien Klin Wochenschr; 2005 Jul; 117(13-14):457-61. PubMed ID: 16091872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate-specific antigen testing in general practice: a survey among 325 general practitioners in Denmark.
    Jønler M; Eddy B; Poulsen J
    Scand J Urol Nephrol; 2005; 39(3):214-8. PubMed ID: 16118092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for prostate cancer: updated experience from the Tyrol study.
    Horninger W; Berger A; Pelzer A; Klocker H; Oberaigner W; Schönitzer D; Severi G; Robertson C; Boyle P; Bartsch G
    Can J Urol; 2005 Feb; 12 Suppl 1():7-13; discussion 92-3. PubMed ID: 15780158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for prostate cancer in U.S. men ACPM position statement on preventive practice.
    Lim LS; Sherin K;
    Am J Prev Med; 2008 Feb; 34(2):164-70. PubMed ID: 18201648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PSA testing in general practice.
    Little B; Ho KJ; Gormley G; Young M
    Prostate Cancer Prostatic Dis; 2003; 6(2):154-8. PubMed ID: 12806375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Has there been a change in practice of screening for prostate cancer with prostate-specific antigen in Ontario?
    Bunting PS
    Clin Biochem; 2004 Oct; 37(10):898-903. PubMed ID: 15369721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate specific antigen screening for prostate cancer: knowledge of, attitudes towards, and utilization among primary care physicians.
    Tasian GE; Cooperberg MR; Cowan JE; Keyashian K; Greene KL; Daniels NA; Carroll PR; Chan JM
    Urol Oncol; 2012; 30(2):155-60. PubMed ID: 20800514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Screening of the prostate cancer. "lnstantaneous" of a daily practice among 300 general practitioners of the canton of Vaud].
    Praz V; Jichlinski P; Aymon D; Leisinger HJ
    Rev Med Suisse; 2005 Dec; 1(44):2840-2. PubMed ID: 16382715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opportunistic prostate-specific antigen screening in Italy: 6 years of monitoring from the Italian general practice database.
    D'Ambrosio GG; Campo S; Cancian M; Pecchioli S; Mazzaglia G
    Eur J Cancer Prev; 2010 Nov; 19(6):413-6. PubMed ID: 20679895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dissemination of evidence-based information about PSA test and prostatic cancer to physicians].
    Norderhaug IN; Wisløff T; Fosså S; Sandberg S; Malde K; Forland F; Førde OH
    Tidsskr Nor Laegeforen; 2004 Nov; 124(22):2893-5. PubMed ID: 15550959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for prostate cancer: what do general practitioners think?
    Morris J; McNoe B
    N Z Med J; 1997 May; 110(1044):178-82. PubMed ID: 9201202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
    Agalliu I; Weiss NS; Lin DW; Stanford JL
    Cancer Causes Control; 2007 Nov; 18(9):931-7. PubMed ID: 17641982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [PSA analyses in three Norwegian counties in 1999].
    Skovlund E; Fosså SD
    Tidsskr Nor Laegeforen; 2000 Sep; 120(21):2539-41. PubMed ID: 11070992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-specific patterns of prostate-specific antigen testing among primary care physician visits.
    McNaughton Collins M; Stafford RS; Barry MJ
    J Fam Pract; 2000 Feb; 49(2):169-72. PubMed ID: 10718695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.